DNAxs/DNAStatistX: Development and validation of a software suite for the data management and probabilistic interpretation of DNA profiles.


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
09 2019
Historique:
received: 23 05 2019
revised: 19 06 2019
accepted: 20 06 2019
pubmed: 30 6 2019
medline: 20 12 2019
entrez: 30 6 2019
Statut: ppublish

Résumé

The data management, interpretation and comparison of sets of DNA profiles can be complex, time-consuming and error-prone when performed manually. This, combined with the growing numbers of genetic markers in forensic identification systems calls for expert systems that can automatically compare genotyping results within (large) sets of DNA profiles and assist in profile interpretation. To that aim, we developed a user-friendly software program or DNA eXpert System that is denoted DNAxs. This software includes features to view, infer and match autosomal short tandem repeat profiles with connectivity to up and downstream software programs. Furthermore, DNAxs has imbedded the 'DNAStatistX' module, a statistical library that contains a probabilistic algorithm to calculate likelihood ratios (LRs). This algorithm is largely based on the source code of the quantitative probabilistic genotyping system EuroForMix [1]. The statistical library, DNAStatistX, supports parallel computing which can be delegated to a computer cluster and enables automated queuing of requested LR calculations. DNAStatistX is written in Java and is accessible separately or via DNAxs. Using true and non-contributors to DNA profiles with up to four contributors, the DNAStatistX accuracy and precision were assessed by comparing the DNAStatistX results to those of EuroForMix. Results were the same up to rare differences that could be attributed to the different optimizers used in both software programs. Implementation of dye specific detection thresholds resulted in larger likelihood values and thus a better explanation of the data used in this study. Furthermore, processing time, robustness of DNAStatistX results and the circumstances under which model validations failed were examined. Finally, guidelines for application of the software are shared as an example. The DNAxs software is future-proof as it applies a modular approach by which novel functionalities can be incorporated.

Identifiants

pubmed: 31254947
pii: S1872-4973(19)30228-5
doi: 10.1016/j.fsigen.2019.06.015
pii:
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-89

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Corina C G Benschop (CCG)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: c.benschop@nfi.nl.

Jerry Hoogenboom (J)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: j.hoogenboom@nfi.nl.

Pauline Hovers (P)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: p.hovers@nfi.nl.

Martin Slagter (M)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: m.slagter@nfi.nl.

Dennis Kruise (D)

Netherlands Forensic Institute, Division of Digital and Biometric Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: d.kruise@nfi.nl.

Raymond Parag (R)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: r.parag@nfi.nl.

Kristy Steensma (K)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: k.steensma@nfi.nl.

Klaas Slooten (K)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: k.slooten@nfi.nl.

Jord H A Nagel (JHA)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: j.nagel@nfi.nl.

Patrick Dieltjes (P)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: p.dieltjes@nfi.nl.

Vincent van Marion (V)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: v.van.marion@nfi.nl.

Heidi van Paassen (H)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: h.van.paassen@nfi.nl.

Jeroen de Jong (J)

Netherlands Forensic Institute, Division of Digital and Biometric Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: j.de.jong@nfi.nl.

Christophe Creeten (C)

Netherlands Forensic Institute, Division of Digital and Biometric Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: c.creeten@nfi.nl.

Titia Sijen (T)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: t.sijen@nfi.nl.

Alexander L J Kneppers (ALJ)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, the Netherlands. Electronic address: s.kneppers@nfi.nl.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH